PRESENTATION

Q3 FY2026 — Presentation

Q3 FY2026PDF · 27 pages7.2 MB
1	© 2026 Lamb Weston, Inc. All Rights Reserved
Lamb Weston
Fiscal Third Quarter 2026 Earnings
April 1, 2026

-- 1 of 27 --

© 2026 Lamb Weston, Inc. All Rights Reserved
Forward-looking Statements
Important Notice
This presentation contains forward-looking statements within the meaning of the federal securities laws. Words such as “continue,” “increase,” “take,” “manage,” “act,” “reduce,” “exceed,” “reinvest,”
“support,” “deliver,” “improve,” “strengthen,” “achieve,” “prioritize,” “build,” “expect,” “will,” “decline,” “execute,” “focus,” “outlook,” “forecast,” “anticipate,” and variations of such words and similar expressions
are intended to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, statements regarding: the Company’s business and financial outlook and
prospects; the Company’s plans and strategies and anticipated benefits therefrom, including with respect to Focus to Win, the Cost Savings Program, and the Restructuring Plan; capital expenditures and
investments; costs and SG&A; potato crop; cash flows; liquidity; dividends; anticipated conditions in the Company’s industry; and the global economy. These forward-looking statements are based on
management’s current expectations and are subject to uncertainties and changes in circumstances. Investors should understand that these statements are not guarantees of performance or results. Many
factors could affect these forward-looking statements and the Company’s actual financial results and cause them to vary materially from the expectations contained in the forward-looking statements.
Investors should refer to the Company’s Annual Report on Form 10-K for the year ended May 25, 2025, and the Company’s other filings with the SEC for a discussion of such factors and certain risks and
uncertainties to which the Company is subject. The Company cautions readers not to place undue reliance on any forward-looking statements included in this presentation, which speak only as of the date
of this presentation. The Company undertakes no responsibility for updating these statements, except as required by law.
In addition to U.S. GAAP financial information, this presentation includes certain non-GAAP financial measures that should be viewed in addition to, and not as an alternative for, financial measures
prepared in accordance with GAAP. These non-GAAP measures are not substitutes for their comparable GAAP financial measures, such as net income, cash flow, diluted earnings per share or other
measures prescribed by GAAP, and there are limitations to using non-GAAP financial measures. For example, the non-GAAP financial measures included in this presentation may differ from similarly titled
non-GAAP financial measures presented by other companies, and other companies may not define these non-GAAP financial measures the same way as the Company does. Management uses these non-
GAAP financial measures to assist in analyzing what management views as the Company’s core operating performance for purposes of business decision making. Management believes that presenting
these non-GAAP financial measures provides investors with useful supplemental information because they (i) provide meaningful supplemental information regarding financial performance by excluding
impacts of foreign currency exchange translation and unrealized derivative activities and other items affecting comparability between periods; (ii) permit investors to view the Company’s operating and
financial performance using the same tools that management uses to evaluate performance across periods and to make budgeting, operating and strategic decisions; and (iii) otherwise provide
supplemental information that may be useful to investors in evaluating the Company’s operating and financial performance. In addition, the Company believes that the presentation of these non-GAAP
financial measures, when considered together with the most directly comparable GAAP financial measures and corresponding reconciliations to those GAAP financial measures, provides investors with
additional tools to understand the factors and trends affecting the Company’s underlying business than could be obtained absent these disclosures. Please see the reconciliations of non-GAAP financial
measures to the most directly comparable GAAP measure set forth in the Appendix to this presentation.
The Company has also provided guidance in this presentation with respect to Adjusted EBITDA, a non-GAAP financial measure. The Company cannot predict certain items that are included in reported
GAAP results, including items such as costs and other charges relating to the Cost Savings Program, Restructuring Plan or other cost savings initiatives; strategic developments; impacts of unrealized
mark-to-market derivative gains/losses; impacts of foreign currency exchange gains/losses; impacts of blue chip swap transactions; other non-recurring items; and other items impacting comparability. This
list is not inclusive of all potential items and the items that cannot be predicted can be highly variable and could potentially have significant impacts on the Company’s GAAP financial measures. As such,
prospective quantification of these items is not feasible without unreasonable efforts, and a reconciliation of forward-looking Adjusted EBITDA to net income has not been provided.
2

-- 2 of 27 --

3	© 2026 Lamb Weston, Inc. All Rights Reserved
Today’s Presenters

-- 3 of 27 --

© 2026 Lamb Weston, Inc. All Rights Reserved 4
Key Messages
• Delivered another solid quarter:
Continue to do what we said we would
do
• Updated guidance: Increasing
midpoint for Net Sales and Adjusted
EBITDA
• North America momentum: Volume up
12% and Net Sales increased 5%
• Managing International business in
the near term and protecting
profitability
• Controlling what we can control,
acting with urgency and being
disciplined in our capital investments

-- 4 of 27 --

5	© 2026 Lamb Weston, Inc. All Rights Reserved
First Year Progress
• Launched Focus to Win strategy for
targeted decision-making and actions
• Established aggressive cost savings
targets - On track to exceed $250M target
• Selectively reinvested savings in
support of customers
• Improvements in execution to deliver
high consistency and quality for
customers and commitment to product
innovation
• Structural improvements in costs and
capital
• Bolstering organization talent and
refreshed board
First Year Progress
5

-- 5 of 27 --

© 2026 Lamb Weston, Inc. All Rights Reserved
• Building an agile and best-in-
class supply chain
• Operating efficiently and
consistently
• Balancing supply and
demand
◦ Curtailing production as
needed
◦ Closing production
facilities that don't meet
customer and efficiency
standards
◦ Restarting production
seamlessly
Strengthen Customer
Partnerships
• Streamlined U.S. commercial
go-to-market strategy in initial
Focus to Win strategy
• Direct sales team positively
impacting selling on the street
• Key differentiator and core
component of our customer
partnership model
• Augmented with broker model
in key channels to immediately
compete effectively
Achieve Executional
Excellence
Focus to Win Progress
6

-- 6 of 27 --

7	© 2026 Lamb Weston, Inc. All Rights Reserved
Focus to Win Progress
Set the Pace for
Innovation
• Grown In Idaho new
brand positioning
launch
• Foundational consumer
research
• Brand rooted in REAL
and created for people
who value where their
food comes from
• New packaging rolling
out

-- 7 of 27 --

8
© 2026 Lamb Weston, Inc. All Rights Reserved
Potato Crop Update
• North America
• Contract negotiations for 2026 crop nearly complete
• Expect a low to mid-single digit percent decline in price in the
aggregate
• Largely secured the targeted number of acres across our
primary growing regions
• Planting on schedule for the early potato varieties, and we
expect planting for the main harvest to be completed by the
end of April
• Europe
• Fixed-price contract negotiations for the 2026 crop are
underway and progressing as planned
• Based on current indications, overall pricing is pointing toward
a mid-teen percent decline from 2025 on contracted raw
• Contract planning across the European growing regions will
continue through the end of April

-- 8 of 27 --

9
© 2026 Lamb Weston, Inc. All Rights Reserved
Focus to Win:
Strategy Taking Hold
• Focus on our customers
• Executing exceptionally
• Delivering cost savings
• Culture of accountability
and continuous
improvement
• See further opportunities
for structural
improvement in cost and
capital management
Prioritize
Markets &
Channels
Achieve
Executional
Excellence
Set the
Pace for
Innovation
Strengthen
Customer
Partnerships

-- 9 of 27 --

© 2026 Lamb Weston, Inc. All Rights Reserved
Financials
& Outlook
Measuring Success
10
(1) Numbers may vary due to rounding

-- 10 of 27 --

© 2026 Lamb Weston, Inc. All Rights Reserved
Q3 '26 vs Q3 '25 Net Sales • Total LW Q3 ’26 Net Sales +3% vs. Q3 ’25, including
foreign currency +$47M
• Sales flat on constant currency(1) basis
• Volume +7%
• Price/Mix (7)% (constant currency)(2)
• North America Net Sales +5%:
• Volume +12%: Customer wins, share gains and
strong retention
• Price/Mix (7)%(2): Price and trade support of
customers; Adverse product mix as consumers
shift toward value-oriented channels and brands,
and chain restaurants; half price and half mix
• International Net Sales (1)%, including favorable
foreign currency of $44M (down 9% in constant
currency)(1)
• Volume (2)%: Softer demand in key markets;
more challenging comparison vs. +12% volume
growth in Q3 FY 2025; growth in China and Latin
America
• Price/Mix in constant currency (7)%(2): Price
and trade support for customers; unfavorable
geographic and customer mix 11
(1) Net sales at constant currency is a non-GAAP financial measure.
See GAAP to non-GAAP reconciliations at the end of the presentation
(2) Price/Mix excludes impact of foreign currency
$ Millions
$1,521 $1,565
Q3'F25 	NA Volume International
Volume
NA Price/mix
(2)
International
Price/mix (2)
FX Impact 	Q3'F26

-- 11 of 27 --

© 2026 Lamb Weston, Inc. All Rights Reserved
Q3 '26 vs Q3 '25 Adjusted EBITDA(1) • Adjusted EBITDA(1) declined $101M
• Adjusted Gross Profit(1) declined $93M
• Unfavorable price/mix
• Higher manufacturing costs per pound due to:
• $33M net pre-tax write-off of excess raw
potatoes in the International segment
• Higher fixed factory absorption in Europe and
Latin America
• Earlier recognition of seasonal benefit of
processing from field in FY 2026
• Input cost inflation (excluding raw potatoes) and tariff
impact
• Partially offset by
• Higher sales volumes
• Cost savings
• Improved efficiencies in North America
• Adjusted SG&A(1) increased $9M
• Benefits of cost savings more than offset by
• Normalizing compensation and benefit accruals
tied to performance
• $13M of write offs of capitalized costs
associated with projects no longer under
development
12
(1) Adjusted EBITDA, Adjusted Gross Profit, Adjusted SG&A, and Adjusted Equity Earnings are non-GAAP
financial measures. See GAAP to non-GAAP reconciliations at the end of the presentation
$ Millions
$373
$272
Q3'F25 	Adjusted Gross
Profit
Adjusted SG&A 	Adjusted Equity
Earnings
Q3'F26

-- 12 of 27 --

© 2026 Lamb Weston, Inc. All Rights Reserved
Driving SG&A Efficiency • SG&A Review
• Engaged outside advisors to review SG&A
efficiency
• Developed targeted action plans to reduce overall
SG&A through Cost Savings Program
• Revenue-linked A&P and royalties relatively flat as a
percent of sales
• Changes in Adjusted SG&A relate to:
• Noncash depreciation and amortization for
strategic IT investments
• Asset impairments
• Changes in incentive payout targets
• Adjusted for depreciation and amortization, asset
impairments, and normalized incentives at 1X
payout:
• Normalized Current: ~7.8% of sales
• Down 70 bps vs FY 2023
• Up 70 bps vs FY 2019
• Executing initial SG&A reductions and actively
identifying additional efficiency opportunities
13
Adj. SG&A and Normalized SG&A as a % of Net Sales
8.2%
9.8%
9.1%
7.1%
8.5%
7.8%
Normalized SG&A 	D&A 	Asset Impairment 	Normalized Incentive
FY19 	FY23 	FY26 Est.
—%
2.0%
4.0%
6.0%
8.0%
10.0%
EMEA Acquisition
IT Modernization
Cost Savings
Disciplined Investment
(1)Adj. SG&A and Normalized SG&A are non-GAAP financial measures. See
GAAP to non-GAAP reconciliations at the end of the presentation.
~

-- 13 of 27 --

© 2026 Lamb Weston, Inc. All Rights Reserved
Q3 '26 vs Q3 '25 Adjusted EBITDA
by Segment
• Adjusted EBITDA(1) declined $101M
• North America Segment
• Adjusted EBITDA (4)% or $13M
• Higher sales volumes
• Lower manufacturing costs per pound
• Lower Adjusted SG&A
• Benefits from cost savings initiative
• More than offset by:
• Price and trade in support for customers
• Mix shift
• International Segment
• Adjusted EBITDA declined $76M
• Lower sales volumes in Europe
• Higher manufacturing costs per pound
• $33M net pre-tax charge for write-off of
excess raw potatoes
• Higher fixed factory burden from
underutilized facilities in Europe and Latin
America
• Input cost inflation (excluding raw potatoes)
• Partially offset by:
• Benefits of cost savings initiatives 14
$ Millions
$373
$272
Q3'F25 	North America 	International 	Unallocated 	Q3'F26
(1) Adjusted EBITDA, Adjusted Gross Profit, Adjusted SG&A, and
Adjusted Equity Earnings are non-GAAP
financial measures. See GAAP to non-GAAP reconciliations at the end
of the presentation

-- 14 of 27 --

15
© 2026 Lamb Weston, Inc. All Rights Reserved
Leverage(2)	Fiscal 2026 YTD
Cash Flow Liquidity(1)
Strong Operating Cash Flow and Capital Discipline
• $596M of net cash provided
by operating activities
• $110M increase vs FY25
• Strong working capital
execution
• $257M capital
expenditures(3)
• Down $307M vs. FY25,
reflecting focused capital
investment
• $339M in Free Cash Flow(2)
• $417M increase vs. FY25
(1) As of February 22, 2026
(2) Net debt, Net debt to Adjusted EBITDA leverage ratio, and free cash flow are non-GAAP financial measures.
See GAAP to non-GAAP reconciliations at the end of the presentation
(3) Net of proceeds from blue chip swap transactions
• Balanced leverage
• ~$3.9B of net debt(2)
• 3.4X Net debt to
Adjusted EBITDA
leverage ratio,(2)
• In line with last year
and with our balance
sheet priorities
• Strong operating cash flow and
efficient use of capital
• Prioritizing maintenance,
modernization, and
environmental expenditures
• Updated FY 2026 Capex
forecast: ~$400M
• Strong liquidity position
• $1.3B availability under
revolving credit facility

-- 15 of 27 --

16
© 2026 Lamb Weston, Inc. All Rights Reserved
Shareholder Value Through Consistent Capital Returns
$2.1B+ Returned Since Spin-off
Cumulative Cash Returned to Shareholders
($ in millions)
Dividend Policy
• 9 consecutive years of increase in dividend per share
since spin-off
• Paid $155M in first three quarters of FY 2026
• Paid Q4 FY 2026 dividend on February 27, 2026
• Quarterly dividend of $0.38 per share declared on
March 31, 2026; payable on June 5, 2026
Share Repurchases
• Repurchased ~$50M through Q3 2026
• 10b5-1 plan initiated; Repurchased 1,053,429 shares
in March at a weighted average price of $41.50
• As of March 30, approximately $264 million remained
available under the plan
(1) Excluding shares withheld from employees to cover income and payroll taxes on equity awards that vested during the period.
$2.1B+
$27 	$138 $251 $372 $508 $646 $792 $966 $1,173 $1,328
$32
$55 $80
$231
$276
$486
$768
$818
Dividends 	Share Repurchases
2017 	2018 	2019 	2020 	2021 	2022 	2023 	2024 	2025 	YTD
3Q'26
YTD Capital Returned to Shareholders
• $205M in dividends and share repurchases

-- 16 of 27 --

17
© 2026 Lamb Weston, Inc. All Rights Reserved
Updating Fiscal 2026 Outlook
Prior Fiscal 2026
Guidance
Updated Fiscal 2026
Guidance
Net Sales $6.35B - $6.55B $6.45B - $6.55B
Adjusted EBITDA(1) $1.00B - $1.20B $1.08B - $1.14B
Capital
Expenditures Approximately $500M Approximately $400M
Additional Guidance Items:
Updated
• Interest Expense ~$180M
• Depreciation & Amortization ~$395M
• FY Tax Rate ~28%
The Company's net sales guidance includes an
approximate 1.8% benefit from an anticipated favorable
foreign currency translation.
The guidance also reflects the Company's current
assessment of the anticipated impact of enacted tariffs by
the U.S. and other countries but does not include potential
effects of evolving trade policies or the potential for refunds,
if any, relating to legal challenges or policy reversals.
The guidance range takes into account the current
expectation for ongoing disruption in certain markets in the
Middle East.
The fiscal 2026 outlook includes the contribution of a 53rd
week in the fiscal period, which occurs in the fourth quarter
of F2026.
(1) Adjusted EBITDA is a non-GAAP financial measure. See information regarding non-GAAP financial measures on
slide 2 of this presentation.

-- 17 of 27 --

© 2026 Lamb Weston, Inc. All Rights Reserved 18
Closing Remarks
• Delivered another solid quarter:
Continue to do what we said we
would do in evolving environment
• North America executing well, with
room to grow
• Fortifying international focus and
taking actions to manage costs
and competitive position
• Controlling what we can control,
acting with urgency and reducing
capital intensity

-- 18 of 27 --

19	© 2026 Lamb Weston, Inc. All Rights Reserved
Q&A

-- 19 of 27 --

20	© 2026 Lamb Weston, Inc. All Rights Reserved
Appendix
(1) Numbers may vary due to rounding

-- 20 of 27 --

21
© 2026 Lamb Weston, Inc. All Rights Reserved
GAAP to non-GAAP reconciliation for the thirteen weeks ended
February 22, 2026 and February 23, 2025
Thirteen Weeks Ended February 22, 2026 Gross Profit SG&A
Cost Savings
Program and
Restructuring
Expenses
Income
From
Operations
Interest
Expense
Income
Tax Expense
(Benefit)(1)
Equity
Method
Investment
Earnings Net Income
Diluted
EPS
As reported $ 332 $ 157 $ 48 $ 127 $ 45 $ 30 $ 3 $ 54 $ 0.39
Unrealized derivative gains and losses (11) — — (11) — (3) — (8) (0.06)
Foreign currency exchange gains — 12 — (12) — (3) — (9) (0.06)
Stock-based compensation (2) — (11) — 11 — 2 — 9 0.06
Items impacting comparability:
Cost Savings Program, Restructuring Plan, and other expenses 7 — (48) 56 — 1 — 54 0.39
Total adjustments (4) 1 (48) 44 — (3) — 46 0.33
Adjusted (3) $ 328 $ 157 $ — $ 170 $ 45 $ 28 $ 3 $ 100 $ 0.72
Thirteen Weeks Ended February 23, 2025
As reported $ 423 $ 164 $ 10 $ 249 $ 47 $ 58 $ 2 $ 146 $ 1.03
Unrealized derivative gains (3) 3 — (6) — (1) — (5) (0.04)
Foreign currency exchange losses — (7) — 7 — 2 — 5 0.04
Blue chip swap transaction gains — 1 — (1) — — — — —
Stock-based compensation (2) — (9) — 9 — 1 — 8 0.05
Item impacting comparability:
Restructuring Plan expenses 1 — (10) 10 — 3 — 8 0.05
Shareholder activism expense — (4) — 4 — 1 — 3 0.02
Total adjustments (2) (16) (10) 24 — 5 — 18 0.12
Adjusted (3) $ 420 $ 148 $ — $ 272 $ 47 $ 63 $ 2 $ 164 $ 1.15
(1) Items are tax effected at the marginal rate based on the applicable jurisdiction.
(2) Beginning with the first quarter of fiscal 2026, net non-cash expenses arising from stock-based compensation awards are excluded from Adjusted SG&A for the current and prior year period.
(3) See information regarding non-GAAP financial measures on slide 2 - "Forward Looking Statements" of this presentation.

-- 21 of 27 --

22
© 2026 Lamb Weston, Inc. All Rights Reserved
GAAP to non-GAAP reconciliation of Adjusted and Normalized SG&A
% of Net Sales FY19 FY23
SG&A 8.9 % 10.3 %
Less:
Unrealized derivative gains and losses — % 0.1 %
Foreign currency gains and losses 0.1 % 0.2 %
Stock-based compensation 0.6 % 0.6 %
Integration and acquisition-related items, net — % (0.4) %
Adjusted SG&A 8.2 % 9.8 %
Less:
Depreciation 0.3 % 0.2 %
Amortization — % 0.1 %
AIP/SIP (100%) 0.8 % 1.0 %
Normalized SG&A 7.1 % 8.5 %

-- 22 of 27 --

23
© 2026 Lamb Weston, Inc. All Rights Reserved
GAAP to non-GAAP reconciliation of Adjusted EBITDA for the thirteen
weeks ended February 22, 2026 and February 23, 2025
Thirteen Weeks Ended
February 22,
2026
February 23,
2025
Net income $ 54 $ 146
Interest expense, net 45 47
Income tax expense 30 58
Income from operations including equity method investment
earnings (1) 129 251
Depreciation and amortization (2) 99 99
Unrealized derivative gains (3) (11) (6)
Foreign currency exchange (gains) losses (4) (12) 7
Blue chip swap transaction gains (5) — (1)
Stock-based compensation (6) 11 9
Items impacting comparability:
Cost Savings Program, Restructuring Plan, and other
expenses (7) 56 10
Shareholder activism expense (8) — 4
Adjusted EBITDA (9) $ 272 $ 373
Segment Adjusted EBITDA
North America $ 290 $ 303
International 19 94
Unallocated corporate costs (10) (37) (24)
Adjusted EBITDA $ 272 $ 373

-- 23 of 27 --

24
© 2026 Lamb Weston, Inc. All Rights Reserved
GAAP to non-GAAP reconciliation of Adjusted EBITDA for the thirteen
weeks ended February 22, 2026 and February 23, 2025
(1) Lamb Weston holds a 50 percent equity interest in a U.S. potato processing joint venture, Lamb-Weston/RDO Frozen (“Lamb Weston RDO”). Lamb Weston accounts for its investment in Lamb Weston RDO
under the equity method of accounting. See Note 6, Other Assets, of the Notes to Consolidated Financial Statements in the Company’s Form 10-K for the fiscal year ended May 25, 2025, filed with the SEC on
July 23, 2025, for more information.
(2) Depreciation and amortization includes interest expense, income tax expense, and depreciation and amortization from equity method investments of $2 million and $2 million for the thirteen weeks ended
February 22, 2026 and February 23, 2025, respectively.
(3) Unrealized gains related to mark-to-market adjustments associated with commodity hedging contracts were $11 million ($8 million after-tax, or $0.06 per share) and $6 million ($5 million after-tax, $0.04 per share),
for the thirteen weeks ended February 22, 2026 and February 23, 2025, respectively.
(4) Foreign currency exchange gains of $12 million ($9 million after-tax, or $0.06 per share) for the thirteen weeks ended February 22, 2026, and losses of $7 million ($5 million after-tax, or $0.04 per share) for the
thirteen weeks ended February 23, 2025.
(5) Blue chip swap transaction gains of $1 million (before and after-tax, or $— per share) for the thirteen weeks ended February 23, 2025. The Company entered into blue chip swap transactions to transfer U.S.
dollars into Argentina primarily in connection with funding its capacity expansion in Argentina. The blue chip swap rate can diverge significantly from Argentina's official rate.
(6) Stock-based compensation of $11 million ($9 million after-tax, or $0.06 per share) and $9 million ($8 million after-tax, or $0.05 per share) for the thirteen weeks ended February 22, 2026 and February 23, 2025,
respectively.
(7) The thirteen weeks ended February 22, 2026, includes total pre-tax cash charges totaling $56 million ($54 million after-tax, or $0.39 per share) related to the Cost Savings Program, Restructuring Plan and other
activities (collectively, the "Plans"). The thirteen weeks ended February 23, 2025 includes total pre-tax charges totaling $10 million ($8 million after-tax, or $0.05 per share) related to the Restructuring Plan. Refer
to Footnote 4, Cost Savings Program and Restructuring, in the Condensed Notes to Consolidated Financial Statements (Unaudited) within the Company's Form 10-Q filed on April 1, 2026, for more information
related to the Plans.
(8) Represents advisory fees related to shareholder activism matters.
(9) See information regarding non-GAAP financial measures on slide 2 - "Forward Looking Statements" of this presentation.
(10) Results for the Company’s two operating segments reflect corporate support staff and services that are directly allocable to those segments. Unallocated corporate costs include costs related to corporate support
staff and other support services, which include, but are not limited to, costs associated with the Company’s administrative, information technology, human resources, finance, and accounting functions that are not
specifically allocated to the segments. In the table above, unallocated corporate costs exclude unrealized derivative gains and losses, foreign currency exchange gains and losses, blue chip swap transaction
gains, stock-based compensation, and items impacting comparability. These items are added to net income as part of the reconciliation of net income to Adjusted EBITDA.

-- 24 of 27 --

25
© 2026 Lamb Weston, Inc. All Rights Reserved
GAAP to non-GAAP reconciliation of Adjusted EBITDA for the Last
Twelve Months
Thirteen Weeks Ended
(in millions) May 25, 2025(1) August 24,
2025(2)
November 23,
2025(3)
February 22,
2026(4)
Last Twelve
Months
Net income $ 120 $ 64 $ 62 $ 54 $ 300
Interest expense, net 44 44 44 45 177
Income tax expense 21 48 36 30 135
Income from operations including equity method investment earnings 185 156 142 129 612
Depreciation and amortization 96 96 100 99 391
Unrealized derivative (gains) losses (11) (5) 12 (11) (15)
Foreign currency exchange (gains) losses (2) (5) 7 (12) (12)
Blue chip swap transaction gains (1) — — — (1)
Stock-based compensation 9 11 10 11 41
Items impacting comparability:
Cost Savings Program, Restructuring Plan, and other expenses 16 32 14 56 118
Shareholder activism expense 1 4 — — 5
Pension settlement — 13 1 — 14
Adjusted EBITDA $ 293 $ 302 $ 286 $ 272 $ 1,153
(1) See the Recast of Adjusted EBITDA for the thirteen weeks ended May 25, 2025, on the Lamb Weston Investor Relations Events & Presentations page.
(2) Refer to the Form 8-K and related Exhibit 99.1 Press Release of Lamb Weston Holdings, Inc. dated September 30, 2025, for the thirteen weeks ended August 24, 2025.
(3) Refer to the Form 8-K and related Exhibit 99.1 Press Release of Lamb Weston Holdings, Inc. dated December 19, 2025, for the thirteen weeks ended November 23, 2025.
(4) See footnotes (1) - (10) to the GAAP to non-GAAP Adjusted EBITDA reconciliation for the thirteen weeks ended February 22, 2026 and February 23, 2025

-- 25 of 27 --

26
© 2026 Lamb Weston, Inc. All Rights Reserved
GAAP to non-GAAP reconciliation of Net Sales at Constant Currency
for the thirteen weeks ended February 22, 2026(1)
GAAP to non-GAAP reconciliations of net debt, leverage ratio and free
cash flow(1)
Thirteen Weeks Ended February 22, 2026 Net Sales Currency
Net Sales at
Constant
Currency
North America $ 1,035 $ (4) $ 1,031
International 530 (44) 486
$ 1,565 $ (47) $ 1,517
Leverage Ratio
February 22,
2026
Total Debt $ 3,993
Less: Cash 58
Net Debt $ 3,935
Trailing Twelve Month Adjusted EBITDA $ 1,153
Net Debt/Adj. EBITDA 3.4 x
Free Cash Flow
February 22,
2026
Operating Cash Flow $ 596
Less: Capital Expenditures 257
Total Free Cash Flow $ 339
(1) All dollar amounts in millions

-- 26 of 27 --



-- 27 of 27 --